NovaBay Pharmaceuticals Inc

General ticker "NBY" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $2.1M

NovaBay Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -42.5%.

Estimated limits based on current volatility of 4.0%: low 0.49$, high 0.53$

Factors to consider:

  • Current price 89.3% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [4.84$, 16.05$]
  • 2024-12-30 to 2025-12-30 estimated range: [4.85$, 13.46$]

Financial Metrics affecting the NBY estimates:

  • Negative: Non-GAAP EPS, $ of -35.71 <= 0.10
  • Negative: Operating profit margin, % of -25.36 <= 1.03
  • Negative: Operating cash flow per share per price, % of -77.98 <= 2.35
  • Negative: negative Net income
  • Negative: Inventory ratio change, % of 6.18 > 1.08
  • Negative: Industry operating profit margin (median), % of -70.04 <= 2.14

Similar symbols

Short-term NBY quotes

Long-term NBY plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $10.20MM $14.40MM $14.73MM
Operating Expenses $19.07MM $28.82MM $19.73MM
Operating Income $-8.86MM $-14.42MM $-5.00MM
Non-Operating Income $3.04MM $3.81MM $-4.64MM
R&D Expense $0.04MM $0.17MM $0.07MM
Income(Loss) $-5.82MM $-10.61MM $-9.64MM
Profit(Loss) $-5.82MM $-10.61MM $-9.64MM
Stockholders Equity $10.17MM $10.55MM $3.31MM
Inventory $3.22MM $3.44MM $2.88MM
Assets $23.98MM $16.40MM $9.03MM
Operating Cash Flow $-9.19MM $-6.65MM $-4.13MM
Capital expenditure $0.05MM $0.11MM $0.02MM
Investing Cash Flow $-12.04MM $-0.11MM $-0.02MM
Financing Cash Flow $16.79MM $4.63MM $1.91MM
Earnings Per Share* $-184.09 $-353.59 $-138.65

* EPS are Split Adjusted, recent splits may be reflected with a delay.